USD10
CNTB Shares
About Connect Biopharma HldgsConnect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
USD10
CNTB Shares
About Connect Biopharma HldgsConnect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
Stats
TRADING WINDOW
Open
CLOSES AT
8:00 PM GMT+0
MARKET CAP
$153.73M
OPEN PRICE
$2.66
LOW (1Y)
$0.51
HIGH (1Y)
$3.82
LOW (24H)
$2.59
HIGH (24H)
$2.78
VOLUME (24H)
$53.74K
87.18%
Price history
Time | Price | Change |
|---|---|---|
Today | $2.66 | |
1 Day | $2.80 | |
1 Week | $3.31 | |
1 Month | $2.47 | |
1 Year | $0.6306 |